insights_auto
Why is PTX down 3,03%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
0,064 AUD
arrow_downward
-3,03%(-0,0020) 1D
5 ოქტ, 16:00:00 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
0,07 AUD
High
0,07 AUD
Low
0,06 AUD
Mkt. cap
69,02 მლნ.
Avg. vol.
1,19 მლნ.
Volume
0,00
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 მლრდ.
No. of employees
3
Open
0,07 AUD
High
0,07 AUD
Low
0,06 AUD
Mkt. cap
69,02 მლნ.
Avg. vol.
1,19 მლნ.
Volume
0,00
52-wk high
0,12 AUD
52-wk low
0,04 AUD
EPS
-0,01 AUD
Shares outstanding
1,14 მლრდ.
No. of employees
3
News stories
From web sources and news partners
Carroll County Mirror-Democrat
·
57 წუთის წინ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq
Yahoo Finance
·
28 წუთის წინ
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
The Business Journals
·
51 წუთის წინ
Georgia Banking Co. plans to go public as it sees a void in the market amid industry consolidation
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd